PLOS BIOLOGY, published by PUBLIC LIBRARY SCIENCE, is a leading open-access journal that has been at the forefront of biological research since its inception in 2003. This high-impact journal (with an impressive Scopus ranking placing it in the top 10% across multiple biological disciplines) aims to disseminate groundbreaking research findings in a variety of fields, including Biochemistry, Genetics, Molecular Biology, Immunology, Microbiology, and Neuroscience. With a commitment to open-access principles, PLOS BIOLOGY ensures that its content is freely available to a global audience, fostering collaboration and innovation among researchers, professionals, and students worldwide. Its Q1 quartile status in 2023 highlights the journal's prestigious standing within the academic community, making it an essential resource for those seeking to stay updated with the latest advancements in biological sciences. The journal's scope extends from 2003 to 2024, reflecting its sustained relevance and impact in driving forward biological discoveries.

Quarterly Reviews of Biophysics, published by Cambridge University Press, is a premier academic journal dedicated to the field of biophysics. With an impressive impact factor reflecting its esteemed reputation, this journal occupies a distinguished position as evidenced by its Q1 category ranking in Biophysics and its ranking of #7 out of 152 in the Scopus database, placing it in the top 5% of its field. The journal has been a significant contributor to the scientific community since its inception in 1968, offering insightful reviews and analysis that bridge the disciplines of biochemistry, genetics, and molecular biology. Quarterly Reviews of Biophysics provides an invaluable platform for researchers, professionals, and students alike to access high-quality, peer-reviewed content that enhances understanding of molecular interactions and systems biology. While Open Access is not currently offered, the journal remains committed to disseminating critical knowledge to advance research and innovation in biophysics.

Methods and Protocols is a prestigious open-access journal published by MDPI, focusing on the critical domain of biochemistry, genetics, molecular biology, and biotechnology. Launched in 2018 and based in Basel, Switzerland, the journal provides a vital platform for sharing innovative methodologies and experimental protocols that advance scientific research and development. With an impressive Q2 ranking in multiple categories, including Biochemistry, Genetics and Molecular Biology, and Biotechnology, it fosters a collaborative environment for researchers and professionals to disseminate their findings. With a mission to enhance reproducibility and transparency in scientific inquiry, Methods and Protocols not only serves as an essential resource for academia but also contributes to the practical application of research in various industries. The journal's open-access model ensures that cutting-edge research is accessible to a global audience, thus promoting knowledge sharing and inspiring future innovations within the scientific community.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

STAR Protocols, published by Elsevier, is an esteemed open access journal that has been at the forefront of providing innovative experimental protocols since its inception in 2020. With a distinct focus on a range of scientific disciplines including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, this journal serves as a vital resource for researchers, professionals, and students alike. The journal holds a commendable status, reflected by its Q1 and Q2 rankings across various relevant categories, ensuring the dissemination of high-impact research methods and findings. With its open access format, STAR Protocols encourages a broad readership and facilitates the sharing of pivotal knowledge in the scientific community, driving forward the culture of transparency and collaboration in research. Positioned in the vibrant academic landscape of the United States, it steadily contributes to the evolution of experimental methodologies, fostering innovation across disciplines.

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, stands as a significant platform for the dissemination of original research in the fields of biochemistry, genetics, and molecular biology, particularly within the context of Indian scientific advancements. With its ISSN 0019-5189 and E-ISSN 0975-1009, the journal has been an essential resource since its inception in 1965, although coverage in prominent databases like Scopus was discontinued in 2018. The journal ranks in the 57th percentile for Biotechnology, as well as in the 27th and 25th percentiles for Molecular Biology and Cell Biology respectively, underscoring its impact and relevance. While currently not an Open Access journal, it continues to provide valuable insights and contributions from researchers and professionals in the growing field of experimental biology. The esteemed contributions published in this journal enhance our understanding of biological processes and foster the development of innovative solutions to contemporary challenges in health and environmental science.

Nature Communications is a premier open-access journal published by NATURE PORTFOLIO, distinguished for its broad scope encompassing Biochemistry, Genetics and Molecular Biology, Chemistry, and Physics and Astronomy. With a remarkable impact factor, this journal has achieved Q1 status in multiple disciplines, reflecting its pivotal role in disseminating high-quality research. Since its establishment, it has provided a vital platform for innovative and interdisciplinary studies, fostering collaboration among scientists worldwide. Situated in the United Kingdom, it has rapidly gained recognition, ranking 7th in Global Physics and Astronomy and Biochemistry, as well as 16th in Chemistry according to Scopus metrics. Accessible since 2015, Nature Communications facilitates the sharing of groundbreaking ideas, making it an invaluable resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery.

Nature Reviews Methods Primers, published by SpringerNature, stands as a pivotal resource in the fields of biochemistry, genetics, molecular biology, and medicine, boasting an impressive impact factor indicative of its scholarly influence. This open-access journal, launched in 2021, aims to disseminate comprehensive, accessible overviews of innovative methodologies that can transform scientific research and clinical practices. With a remarkable Scopus rank of #7 out of 636 in General Medicine and a stellar #3 out of 221 in General Biochemistry, Genetics and Molecular Biology, it resides in the esteemed Q1 Quartile category for its contributions to academia. Researchers, professionals, and students will find Nature Reviews Methods Primers to be an invaluable tool as it bridges the gap between methodology and practical application, enabling advancement in a variety of biomedical fields.

Bio-protocol is an innovative open-access journal dedicated to the advanced fields of biochemistry, immunology, neuroscience, and plant science, published by BIO-PROTOCOL in the United States since 2023. With an E-ISSN of 2331-8325, this journal serves as a pivotal platform for sharing high-quality methodologies and experimental protocols, enabling researchers, professionals, and students to streamline their experimental workflows and enhance reproducibility in scientific research. In 2023, Bio-protocol achieved notable rankings, placing in the Q2 category for biochemistry, genetics, molecular biology, and immunology, as well as Q3 in neuroscience, reflecting its growing influence and relevance in these fields. The journal offers full open access, ensuring that cutting-edge research is freely available, promoting global collaboration and innovation in the life sciences. Engaging with Bio-protocol positions its readers at the forefront of significant scientific advancements and methodological developments.